| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Compass Therapeutics, Inc.'s insiders have accumulated 22,500 shares worth roughly $21K on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
The largest recent buyer is Lerner Neil (Chief Accounting Officer), now holding an estimated $386K in CMPX. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
CMPX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.60M | $43.05M | - | |
| Other | 1.00M | - | - | |
| Other | 1.00M | - | - | |
| CFO | 670.0K | - | - | |
| Other | 420.0K | $386.4K | +22.5K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $4.05 | $81,000.00 | +0.4% | -22.0% | -67.5% | |
| Jan 24, 2023 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $4.19 | $83,800.00 | +0.4% | -30.9% | -67.1% | |
| Nov 25, 2022 | Bisker-Leib Vered79 | Chief Operating Officer | Sell | 24,500 | $4.23 | $103,707.93 | -2.3% | -9.8% | -60.6% | |
| Nov 21, 2022 | Bisker-Leib Vered79 | Chief Operating Officer | Sell | 22,261 | $4.36 | $96,986.30 | -2.0% | -11.2% | -60.5% | |
| Nov 8, 2022 | Gordon Carl L74 | Director, 10% Owner | Buy | 402,000 | $3.21 | $1,290,420.00 | +2.7% | -7.3% | -59.5% | |
| Nov 8, 2022 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 402,000 | $3.21 | $1,290,420.00 | +2.7% | -7.3% | -59.5% | |
| Sep 28, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 10,000 | $2.32 | $23,200.00 | +0.2% | +132.3% | -13.1% | |
| Sep 26, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 15,000 | $2.27 | $34,050.00 | +0.3% | +180.0% | +4.7% | |
| Sep 7, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 15,000 | $3.03 | $45,450.00 | +0.3% | +52.5% | -24.6% | |
| Sep 1, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 15,000 | $2.83 | $42,450.00 | +0.3% | +41.7% | -17.9% |